Trulieve Cannabis Corp.
TRLV | NYSE
$10.28
-$0.32 (-3.02%)
At close: Oct 30, 2026, 4:00 PM ET
$10.40
+$0.12 (+1.17%)
Pre-market:
Nov 2, 2026, 4:58 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 |
|---|---|
Revenue | 1.18B |
Cost of Revenue | 470.01M |
Gross Profit | 711.17M |
Operating Income | 148.32M |
Interest Income | 14.52M |
Pretax Income | 91.47M |
Net Income | -116.38M |
Selling & General & Admin | 445.21M |
Research & Development | n/a |
Other Expenses | 117.63M |
Operating Expenses | 562.85M |
Interest Expense | 63.45M |
Selling & Marketing Expenses | n/a |
Cost & Expenses | 1.03B |
Income Tax Expense | 208.11M |
Shares Outstanding (Basic) | 191.3M |
Shares Outstanding (Diluted) | 191.3M |
EPS (Basic) | -0.61 |
EPS (Diluted) | -0.61 |
EBITDA | 328.33M |
EBIT | 154.93M |
Depreciation & Amortization | 173.4M |
Add to Watchlist
Select watchlists to add or remove TRLV